The literature [21] further claimed that mepivacaine greatly enhanced the release of inflammatory factors in BCC, promoted the phosphorylation of STAT3, and effectively decreased the release of anti-inflammatory factors. The gene discussed is STAT3; the disease is skin basal cell carcinoma.